NCT01288157View on ClinicalTrials.gov

A Study of the Pharmacokinetics of Golimumab in Chinese Male Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

January 31, 2011

Study Completion Date

January 31, 2011

Conditions

Healthy Adult Chinese Males

Interventions

DRUG

Golimumab

Single dose of 100 mg subcutaneously

DRUG

Golimumab

Single dose of 50 mg subcutaneously

Trial Locations (1)

Unknown

Beijing

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Centocor, Inc.

INDUSTRY